132 related articles for article (PubMed ID: 4579783)
1. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
West KA; Roos BE
Confin Neurol; 1972; 34(2):136-42. PubMed ID: 4579783
[No Abstract] [Full Text] [Related]
2. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
West KA; Roos BE
Confin Neurol; 1972; 34(1):136-42. PubMed ID: 4538913
[No Abstract] [Full Text] [Related]
3. [Determination of homovanillic acid in the cerebrospinal fluid of Parkinson's disease patients and control group].
Voto Bernales J; Cruz GA; Davila E
Rev Neuropsiquiatr; 1973 Mar; 36(1):46-52. PubMed ID: 4793023
[No Abstract] [Full Text] [Related]
4. Biochemical aids in the diagnosis of Parkinson's disease.
Chase TN; Eng N; Gordon EK
Ann Clin Lab Sci; 1976; 6(1):4-10. PubMed ID: 1247283
[TBL] [Abstract][Full Text] [Related]
5. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
Extein I; Van Woert M; Roth RH; Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
[TBL] [Abstract][Full Text] [Related]
6. [Approaches to the study of dopamine metabolism in various extrapyramidal diseases].
Barkhatova VP; Kandel' EI; Demina EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1021-9. PubMed ID: 6457476
[TBL] [Abstract][Full Text] [Related]
7. [Cerebrospinal fluid homovanillic acid in paralysis agitans and spinocerebellar degeneration (author's transl)].
Mizuno Y; Ariga T
Rinsho Shinkeigaku; 1979 Jun; 19(6):367-71. PubMed ID: 477137
[No Abstract] [Full Text] [Related]
8. [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
Bernheimer H; Birkmayer W; Hornykiewicz O
Wien Klin Wochenschr; 1966 Jun; 78(23):417-9. PubMed ID: 4229554
[No Abstract] [Full Text] [Related]
9. Concentration of homovanillic acid in the ventricular fluid of patients with Parkinson's disease and other dyskinesias.
Papeschi R; Molina-Negro P; Sourkes TL; Hardy J; Bertrand C
Neurology; 1970 Oct; 20(10):991-5. PubMed ID: 4919352
[No Abstract] [Full Text] [Related]
10. The surgical treatment of Parkinson's disease.
Grant JM
Aust Fam Physician; 1984 May; 13(5 Suppl):12-3. PubMed ID: 6388546
[No Abstract] [Full Text] [Related]
11. Homovanillic acid in the ventricular fluid of patients with Parkinson's disease and other extrapyramidal diseases.
Papeschi R; Molina-Negro P; Sourkes TL; Hardy J; Bertrand C
Laval Med; 1970 Sep; 41(7):899-901. PubMed ID: 5509486
[No Abstract] [Full Text] [Related]
12. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
Inagawa T
Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
[No Abstract] [Full Text] [Related]
13. Amine metabolites in the cerebrospinal fluid in Parkinson's disease and the response to levodopa.
Gumpert J; Sharpe D; Curzon G
J Neurol Sci; 1973 May; 19(1):1-12. PubMed ID: 4715017
[No Abstract] [Full Text] [Related]
14. [Homovanillic acid content in the cerebrospinal fluid as an index of dopamine cerebral metabolism before and after a stereotaxic operation in patients with extrapyramidal hyperkinetic syndromes].
Barkhatova VP; Kandel' EI; Omorova TM; Demina EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1050-5. PubMed ID: 6382885
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal homovanillic acid and parkinsonism.
Miachon S; Dalmaz Y; Cottet-Emard JM; Peyrin L
Biomedicine; 1974 Jul; 21(7):303-8. PubMed ID: 4433665
[No Abstract] [Full Text] [Related]
16. The probenecid test in Parkinson's disease.
Lakke JP; Korf J; Hoorntje S; Schut T; van Praag HM
Psychiatr Neurol Neurochir; 1973; 76(2):139-46. PubMed ID: 4700931
[No Abstract] [Full Text] [Related]
17. [Madopar in the treatment of paralysis agitans: II. TRH activation test, EMG examination and HVA level in cerebrospinal fluid before and after treatment].
Liu DK
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):223-6. PubMed ID: 6790255
[No Abstract] [Full Text] [Related]
18. Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.
Parkes JD; Marsden CD; Rees JE; Curzon G; Kantamaneni BD; Knill-Jones R; Akbar A; Das S; Kataria M
Q J Med; 1974 Jan; 43(169):49-61. PubMed ID: 4822972
[No Abstract] [Full Text] [Related]
19. Tryptophan and monoamine metabolites in ventricular cerebrospinal fluid after severe cerebral trauma.
Hyyppä MT; Långvik VA; Nieminen V; Vapalahti M
Lancet; 1977 Jun; 1(8026):1367-8. PubMed ID: 69086
[No Abstract] [Full Text] [Related]
20. Homovanillic acid in the cerebrospinal fluid of Parkinsonian patients.
Cunha L; Gonçalves AF; Oliveira C; Dinis M; Amaral R
Can J Neurol Sci; 1983 Feb; 10(1):43-6. PubMed ID: 6839227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
